Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 11—November 2006

Seroprevalence of Hepatitis E Virus Infection, Rural Southern People’s Republic of China

Rong-Cheng Li*1, Sheng-Xiang Ge†1, Yan-Ping Li*, Ying-Jie Zheng†2, Yi Nong*, Qing-Shun Guo†, Jun Zhang†, Mun-Hon Ng†, and Ning-Shao Xia†Comments to Author 
Author affiliations: *Guangxi Center for Disease Control and Prevention, Nanning, People's Republic of China; †Xiamen University, Xiamen, People's Republic of China

Cite This Article


Genotype 4 hepatitis E virus (HEV) is the dominant cause of hepatitis E in the People's Republic of China; swine are the principal reservoir. Our study was conducted in 8 rural communities of southern China, where families keep pigs near their homes. Phylogenetic analysis showed that 23 of 24 concurrent virus isolates from this region are genotype 4 strains. Among the study populations, immunoglobulin G anti-HEV seroprevalence accumulated with age at ≈1% per year for persons >60 years of age. After age 30 years, seroprevalence increased at higher rates for male than for female study participants. The overall seroprevalence was 43% (range 25%–66%) among the communities. Infection rates were higher for participants between 25 and 29 years of age. The results suggest that HEV infection probably has been endemic in southern China for <60 years, with swine being the principal reservoir of human HEV infection in recent years.

Hepatitis E virus (HEV), a member of the Hepevirus genus, is an RNA-positive strand virus that resembles calicivirus both morphologically and in organization of its 7.5-kb genome (1). The virus was first identified as the cause of extended waterborne outbreaks of hepatitis, with significant deaths among pregnant women (2). Widely distributed in nature, the virus is detected in swine and other animals—both domestic and wild (35). Based on phylogenetic analysis, the virus isolates can be separated into 4 major groups, genotypes 1–4 (6). While viruses of genotypes 1 and 2 are isolated exclusively from humans, those from genotypes 3 and 4 have also been isolated from swine and other animals (7). Genotype 1 strains are mainly distributed in Asia and the Middle East (8,9), where they frequently cause waterborne outbreaks of hepatitis (10,11). Genotype 2 virus was first detected in Mexico (12). Genotype 3 strains are widely distributed; they have been isolated from swine in North America (13), South America (14), Europe (15), Oceania (16), and Asia (17) and, in some of these areas, from rare, indigenous human cases of hepatitis E (18,19). Genotype 3 virus isolated from wild pigs and deer in Japan was recently found to be the cause of an outbreak of foodborne infection (20,21). Genotype 4 is largely restricted to Asia. The virus was detected in archival swine serum samples in India collected in 1985 (22) and since then has been detected in swine in Taiwan (23), mainland People's Republic of China (5), Indonesia (24), India (22), and Japan (25). Genotype 4 virus causes sporadic cases and is associated with foodborne infection but has not been generally associated with waterborne outbreaks. The different HEV genotypes are indistinguishable serologically (26), however, and studies in primates show cross-protection among the 4 genotypes (27,28).

HEV was first detected in People's Republic of China during an extended outbreak in Xinjiang Province in 1986 (10). The causal agent was a strain of genotype 1 virus, which persisted as the dominant genotype in China until 2000, when genotype 4 emerged as the dominant genotype (29,30). A recent study conducted in 2 swine farming districts of eastern China showed that genotype 4 virus freely circulates among swine and humans: an estimated 9% of swine and 0.3% of humans have asymptomatic infection (31). In seroepidemiologic studies conducted concurrently by these authors, the risk for human HEV infection was associated with occupational contact with swine and swine sewage, making the animals a principal reservoir for human infection.

We describe a seroepidemiologic study of HEV infection in 8 rural communities of southern China and a phylogenetic analysis of the virus circulating in the region. The results showed that HEV infection is endemic in the region and probably has been for at least 60 years. The prevalent virus population is genetically diverse, although dominated by genetically diverse genotype 4 virus.

Materials and Methods

Study Participants

We conducted a cross-sectional and a follow-up seroepidemiologic study of HEV infection in 2003 and 2004 in conjunction with annual health examinations conducted among residents of rural communities in Guangxi Province (GX) in southern China. These exams involve routine clinical examination, routine biochemical testing, and determination of hepatitis A virus (HAV) and hepatitis B virus (HBV) serologic status. Participants were enrolled in the study after providing informed consent; parental consent was obtained for participants <16 years of age. A questionnaire was used to record demographic data, education level, employment, source of water supply, sanitation practices, and household contact with pigs and poultry. Ethical approval for the study was obtained from the Guangxi Institutional Review Board.

Immunoglobulin G (IgG) anti-HEV Assay

An aliquot of serum was obtained from the samples taken for routine biochemical testing and HAV and HBV status and made available for the present study. Serum samples were tested for IgG anti-HEV by using a commercial ELISA (Wan Tai Pharmaceutical Co., Beijing, China), produced with a recombinant peptide corresponding to amino-acid residues 396 to 606 of the major structural protein specified by open reading frame 2 (ORF2) of the HEV genome (32). Serum samples were diluted 1:10, and tested according to manufacturer's instruction. A positive reaction was indicated when the signal:cut-off (S:CO) exceeded 1.5.

Detection of HEV RNA

For the virologic study, serum samples were taken from 24 patients admitted to local hospitals in 2003 and 2004 with serologically diagnosed hepatitis E. Total RNA was extracted from 250 μL of sample with Trizol (Invitrogen). Reverse-transcription polymerase (RT)-PCR was performed as described previously (33,34). Briefly, a 150-nt segment of ORF2, was amplified with primers E1 (5´-CTGTTTAA[C/T]CTTGCTGA CAC-3´,6,260–6,279) and E5 (5´-(A/T)GA[A/G]AGCCAAAGCACATC-3´, nt 6,568–6,551) in the first round of PCR and primers E2 (5´-GACAGAATTGATTTCGTCG-3´, nt 6,298–6,316) and E4 (5´-TG[C/T]TG GTT[A/G]TC[A/G]TAATCCTG-3´, nt 6,486–6,467) in the second round. PCR cycling conditions for both rounds consisted of 35 cycles of denaturation at 94°C for 30 s, annealing at 53°C for 30 s, and extension at 72°C for 40 s. PCR products were purified and sequenced in a forward and reverse direction by using an automatic nucleotide sequencer (ABI model 3730 sequencer, Applied Biosystems, Foster City, CA, USA).

Phylogenetic Analysis

A 150-nt ORF2 segment was amplified from 24 virus isolates from patients with serologically diagnosed acute hepatitis E who were admitted to local hospitals during the period of study. The nucleotide sequence of the amplified products and that of prototypes of different genotypes of HEV strains were aligned by using the MEGA 3.0 software (version 3.0, Genomic sequences of prototype HEV strains (Burma1, M73218; Burma2, D10330; CN-Xinjiang, D110920; CN-genotype4, AJ272108; India1, X98292; Pakistan, M80581; Mexico, M74506; U.S., AF060668) were obtained from GenBank. Phylogenetic trees were generated by the minimum evolution method and the interior branch method; 1,000 resamplings of the data were used to calculate percentage of the branches obtained. The identity between the nucleotide sequences was calculated by using the program MegAlign (DNAstar package version 5.03; Lasergene, DNAstar Inc., Madison, WI, USA).

Statistical Methods

Seroprevalence was standardized for age and sex according to China's national census of 2000. Multivariate unconditional logistic regression analysis was performed with SAS (Version 8.2; SAS Institute Inc., Cary, NC, USA) and was used to identify independent determinants of IgG anti-HEV prevalence and to estimate the level of the associated risk (35).


Serum samples were taken in 2003 from 7,284 participants; a second sample was taken 12 months later from a subpopulation of 3,431 of these persons (Table 1). The study participants were recruited from 8 rural communities situated 50–500 km of one another in southern China. The water supply for this area comes from wells, rivers, and streams. Tap water and sewage treatment are not generally available. The study population was of similar socioeconomic and cultural backgrounds, and, in general, participants had been residing in their respective communities for most of their lives. Farming is the major source of income; most families rear swine and other domestic animals for their own consumption and for sale to supplement family incomes. Within these communities, men commonly migrate to urban centers to seek employment; hence, female participants predominate in the study population.

Table 2 shows the IgG anti-HEV status of the 7,284 study participants from these 8 rural communities in 2003. The age and sex-standardized IgG anti-HEV seroprevalence is 43.5% for the general study population and 25.2%–66.1% for the 8 communities. The age-standardized seroprevalence is 47.1% for male participants and 39.7% for female ones. Multivariate unconditional logistic regression analysis identified age, sex, and community to be independent determinants for IgG anti-HEV seroprevalence, but not other factors such as income, employment, education, and source of water supply. Because rearing pigs and chickens adjacent to one's home is common, most families reside in close proximity to domestic animals whether or not they keep them themselves. Consequently, assessing the risk for infection attributable to this practice was not possible.

Figure 1

Thumbnail of Age specific anti–hepatitis E virus (HEV) seropositive rates in a study population. Age-specific IgG anti-HEV seropositive rates for (A) both sexes or (B) either sex separately (black triangle for male study participant, open triangle for female) were determined for every 5 years from 0 to 69 years of age and for older participants, using samples taken in 2003 from 7,284 persons.

Figure 1. Age specific anti–hepatitis E virus (HEV) seropositive rates in a study population. Age-specific IgG anti-HEV seropositive rates for (A) both sexes or (B) either sex separately (black triangle for male study...

On the basis of results obtained with the samples taken in 2003, the age-specific IgG anti-HEV seropositive rate was calculated in 5-year increments up to 69 years of age and summarily for older participants. The IgG anti-HEV seropositive rate of the general population (Figure 1A) accumulated with age for both male and female participants (Figure 1B). The seropositive rate of the general study population increased at a relatively constant rate of ≈1% per year up to ≈60 years of age, and then remained essentially stable. IgG anti-HEV seropositive rate increased at a similar rate for male and female participants <30 years of age then at higher rate for male participants 30–59 years of age (Figure 1B). Multivariate unconditional logistic regression analysis estimated that IgG anti-seropositive rates were similar for male and female participants up to age 30 years (odds ration [OR] = 0.9, 95% confidence intervals [CI] = 0.7–1.1) but were ≈2-fold higher for male participants >30 years of age (OR = 2.1, 95% CI = 1.7–2.6).

Changes in IgG anti-HEV serologic status occurring in 2004 were determined by using a second sample taken 12 months later from a subpopulation of 3,431 participants (Table 3) from 7 of the 8 communities. The results showed that 4.3% of seronegative participants seroconverted to positive, and 1.4% of seropositive participants underwent negative seroconversion. The overall seropositive rate of the subpopulation increased from 46.2% in 2003 to 49.1% in 2004. The positive seroconversion rate was higher for male participants, but the difference was not statistically significant (p>0.05). One community (Linyun) evidently experienced an undetected outbreak of HEV infection between 2003 and 2004, since its positive seroconversion rate of 17.9% was significantly higher than the positive seroconversion rates of the other communities (p<0.01). In those communities, positive seroconversion rates ranged from 0.7% to 4.2%, but the differences between them were not statistically significant (p>0.05). The negative seroconversion rates were 0%–3.03% among the different communities, also not statistically significant (p > 0.05).

Figure 2

Thumbnail of Changes in immunoglobulin G (IgG) anti-hepatitis E virus (HEV) serologic status, 2003–2004. Age-specific IgG anti-HEV–positive seroconversion (A) and age-specific IgG anti-HEV–negative seroconversion (B), determined for every 5 years of age from 0 to 59 years of age and in older participants, using samples taken 12 months apart from a subpopulation of 3,431 persons.

Figure 2. Changes in immunoglobulin G (IgG) anti-hepatitis E virus (HEV) serologic status, 2003–2004. Age-specific IgG anti-HEV–positive seroconversion (A) and age-specific IgG anti-HEV–negative seroconversion (B), determined for every 5 years of age from...

Age-specific IgG anti-HEV positive seroconversion rates and negative seroconversion rates were calculated in increments of 5 years up to 59 years of age (for 2003, it was 69 years) and then summarized for the older participants. Figure 2A shows that positive seroconversion occurred at all ages. Highest rates occurred among persons in the 25- to 29-year age group (11.8% per year) and ranged from 2.1% to 5.6% per year for the other age groups. On the basis of multivariate unconditional logistic regression analysis, the risk for infection was ≈3-fold higher for persons 25–29 years of age than for those in the other age groups (OR = 3.2, 95% CI = 1.7–5.8).

The overall rate of negative seroconversion was 1.4%. For the 0–4 year age group, this rate was 18.8%, which is ≈15 times higher that of the older age groups (OR = 14.9, 95% CI = 4.9–45.4); however, this rate likely reflects the loss of maternal antibodies. Among the older age groups, negative seroconversion occurred at similar rates of 0 to 3.6% per year.

Figure 3

Thumbnail of Phylogenetic analysis of hepatitis E virus (HEV) isolates. HEV isolates from patients with serologically diagnosed hepatitis E cases admitted in 2003 and 2004 to local hospitals are represented by closed circles. Prototype strains of indicated genotypes are designated according to site of isolation. Numbers on the branches represent (percent) reproduced values calculated from 1,000 resamplings of the data. The bar represents a genetic distance of 0.02-nt substitution per position.

Figure 3. Phylogenetic analysis of hepatitis E virus (HEV) isolates. HEV isolates from patients with serologically diagnosed hepatitis E cases admitted in 2003 and 2004 to local hospitals are represented by closed circles....

All HEV infections observed among the study participants were asymptomatic; no cases of overt hepatitis E were observed. To study HEV prevalence in the communities during our study period, we obtained 24 HEV strains isolated from persons with serologically diagnosed hepatitis E who were admitted to hospitals in Guangxi between 2003 and 2004. Figure 3 shows the phylogenetic tree produced with the alignments of a 150-nt ORF2 sequence. All 24 isolates had distinct nucleotide sequences. One isolate was a genotype 1 virus, which is more closely related to prototype Chinese than to Burmese, Indian, or Pakistani genotype 1 strains. The other 23 isolates were genotype 4 virus related to the Japanese prototype genotype 4 strain. Genotype 4 isolates are genetically diverse, and in our study genetic identity between pairs of isolates ranged from 88.7% to 99.3%, with a mean value of 95.4%.


We undertook a cross-sectional seroepidemiologic study in 2003 to determine the extent of HEV infection occurring in 8 rural communities in southern China. To determine new infections, we obtained a second serum sample from a subgroup of the 2003 study population after 12 months. Genetic analysis was performed on 24 strains of HEV isolated from patients with serologically diagnosed hepatitis E who were admitted to hospitals in the region during the study period.

The IgG anti-HEV assay used in the study was produced with a recombinant peptide of the major HEV structural protein that occurs naturally as a homodimer (36). The 3-dimensional structure of the homodimer appears to model the HEV neutralization sites and other important HEV antigenic determinants located on the virus capsid (34,37). Consequently, IgG anti-HEV determined by this assay correlated with protective immunity (27,38). The antibody is regularly detected in acute- and convalescent-phase serum samples from hepatitis E patients and persists in primates for more than a year after HEV challenge (32). In our study, the average negative seroconversion rate of the antibody produced in response to asymptomatic HEV infection was 1.4% per year. This shows that the IgG antibody determined by this assay is stable and could provide a reliable epidemiologic marker to study HEV infection.

Phylogenetic analyses were conducted by using alignments of a 150-nt ORF2 sequence of 24 isolates from serologically confirmed hepatitis E cases. Based on previous studies (6,33), phylogenetic relationships established on the basis of partial sequences, such as this, are expected to be similar to relationships established from a complete sequence of the viral genome. The 24 virus strains analyzed from hepatitis E patients admitted to local hospitals during the time of the study are generally representative of the virus population prevalent in southern China where our study took place. All 24 isolates are genetically distinct and consist of 1 genotype 1 isolate and 23 genotype 4 isolates.

Zheng et al (31) studying HEV infection in 2 swine farming districts of eastern China showed that most HEV infections were genotype 4, which freely cocirculates among swine and humans. Since viral burden is much higher in swine than in humans, the authors concluded that swine were the principal source of genotype 4 virus for human infection. This contention is supported by seroepidemiologic findings, which suggested that infection may be acquired by contact with these animals or their sewage. Swine may be postulated to represent the principal reservoir of HEV in this current study area also because the prevalent virus population almost entirely comprises genotype 4 isolates and virtually all families raise pigs near their homes. According to this view, the level of infection among humans in each community would be determined primarily by the levels of infection of its swine population. Since the animals are kept close to family homes, humans could be the principal means by which the infection is spread among communities. However, the levels of infection differ substantially among communities, ranging from 25% to 66%, and a silent outbreak occurring in 1 of the communities during the time of the study involving 18% of its population did not spread to neighboring communities. This finding suggests that compared with swine, humans may not be an efficient vector for spreading genotype 4 virus infection.

The cross-sectional seroepidemiologic study showed that HEV infection is endemic in southern China. The average IgG anti-HEV seroprevalence of the population is 43%; participants' ages, sex, and communities are independent determinants. Seroprevalence was found to increase with age at a relatively constant rate of ≈1% per year until 59 years of age, and then remained essentially constant for older age groups. This finding suggests that HEV infection might have been endemic in southern China for > 60 years, so that persons in the 55- to 59-year age group may have been subjected to the same cumulative life-long exposure as older age groups. This estimate is consistent with findings from archival serum samples which indicate that HEV was prevalent in India before 1955 (39).

Our study identified 2 additional risk factors relating to the life style of the study participants. Seroprevalence was ≈2-fold higher for male participants than for female ones after 30 years of age but was similar for both sexes in the younger age groups. This finding probably reflects different roles adopted by males and females once families are established. Moreover, based on results from the follow-up study, the positive seroconversion rate is ≈3-fold higher among those 25–29 years of age than at other ages, which may be related to increased socialization during this stage of life.

In summary, our study showed that HEV infection is endemic in southern China and may have been so for at least 60 years. The prevalent virus is dominated by genetically diverse genotype 4 viruses. Among our study participants, infections seem to be mainly acquired from contact with swine; human-to-human transmission was of secondary importance. Herd immunity is built up separately to differing levels among different communities, leaving substantial proportions of the population vulnerable to HEV. Under such settings, vaccination programs for humans and swine could serve to boost herd immunity among humans and reduce the viral burden of swine herds.

Dr Rong-Cheng Li is a scientist based at the Centers for Disease Prevention and Control of Guangxi Autonomous Region, People's Republic of China. His research interests include emerging viral infections and field trials of candidate vaccines.



We are grateful to Beverly Griffin of Royal Postgraduate Medical School, United Kingdom, for advice and editorial assistance.

Financial support was provided by the National High Technology Research and Development Program of China (grant 2005AA2Z3H20, 2005DFA30820) and Key Science and Technology Project of Fujian Province (grant 2004YZ01-1).



  1. Reyes  GR, Purdy  MA, Kim  JP, Luk  KC, Young  LM, Fry  KE, Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247:13359. DOIPubMed
  2. Khuroo  MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980;68:81824. DOIPubMed
  3. Meng  XJ, Purcell  RH, Halbur  PG, Lehman  JR, Webb  DM, Tsareva  TS, A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A. 1997;94:98605. DOIPubMed
  4. Tei  S, Kitajima  N, Takahashi  K, Mishiro  S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362:3713. DOIPubMed
  5. Wang  YC, Zhang  HY, Xia  NS, Peng  G, Lan  HY, Zhuang  H, Prevalence, isolation, and partial sequence analysis of hepatitis E virus from domestic animals in China. J Med Virol. 2002;67:51621. DOIPubMed
  6. Schlauder  GG, Mushahwar  IK. Genetic heterogeneity of hepatitis E virus. J Med Virol. 2001;65:28292. DOIPubMed
  7. Lu  L, Li  C, Hagedorn  CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:536. DOIPubMed
  8. Tsarev  SA, Binn  LN, Gomatos  PJ, Arthur  RR, Monier  MK, van Cuyck-Gandre  H, Phylogenetic analysis of hepatitis E virus isolates from Egypt. J Med Virol. 1999;57:6874. DOIPubMed
  9. Aye  TT, Uchida  T, Ma  X, Iida  F, Shikata  T, Zhuang  H, Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China. Microbiol Immunol. 1992;36:61521.PubMed
  10. Aye  TT, Uchida  T, Ma  XZ, Iida  F, Shikata  T, Zhuang  H, Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986–1988) of China. Nucleic Acids Res. 1992;20:3512. DOIPubMed
  11. Aggarwal  R, McCaustland  KA, Dilawari  JB, Sinha  SD, Robertson  BH. Genetic variability of hepatitis E virus within and between three epidemics in India. Virus Res. 1999;59:3548. DOIPubMed
  12. Huang  CC, Nguyen  D, Fernandez  J, Yun  KY, Fry  KE, Bradley  DW, Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 1992;191:5508. DOIPubMed
  13. Huang  FF, Haqshenas  G, Guenette  DK, Halbur  PG, Schommer  SK, Pierson  FW, Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol. 2002;40:132632. DOIPubMed
  14. Cooper  K, Huang  FF, Batista  L, Rayo  CD, Bezanilla  JC, Toth  TE, Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J Clin Microbiol. 2005;43:16848. DOIPubMed
  15. van der Poel  WH, Verschoor  F, van der Heide  R, Herrera  MI, Vivo  A, Kooreman  M, Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg Infect Dis. 2001;7:9706. DOIPubMed
  16. Garkavenko  O, Obriadina  A, Meng  J, Anderson  DA, Benard  HJ, Schroeder  BA, Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol. 2001;65:5259. DOIPubMed
  17. Takahashi  M, Nishizawa  T, Okamoto  H. Identification of a genotype III swine hepatitis E virus that was isolated from a Japanese pig born in 1990 and that is most closely related to Japanese isolates of human hepatitis E virus. J Clin Microbiol. 2003;41:13423. DOIPubMed
  18. Kwo  PY, Schlauder  GG, Carpenter  HA, Murphy  PJ, Rosenblatt  JE, Dawson  GJ, Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc. 1997;72:11336. DOIPubMed
  19. Clemente-Casares  P, Pina  S, Buti  M, Jardi  R, Martin  M, Bofill-Mas  S, Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis. 2003;9:44854.PubMed
  20. Tei  S, Kitajima  N, Ohara  S, Inoue  Y, Miki  M, Yamatani  T, Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J Med Virol. 2004;74:6770. DOIPubMed
  21. Tamada  Y, Yano  K, Yatsuhashi  H, Inoue  O, Mawatari  F, Ishibashi  H. Consumption of wild boar linked to cases of hepatitis E. J Hepatol. 2004;40:86970. DOIPubMed
  22. Arankalle  VA, Chobe  LP, Walimbe  AM, Yergolkar  PN, Jacob  GP. Swine HEV infection in south India and phylogenetic analysis (1985–1999). J Med Virol. 2003;69:3916. DOIPubMed
  23. Hsieh  SY, Meng  XJ, Wu  YH, Liu  ST, Tam  AW, Lin  DY, Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol. 1999;37:382834.PubMed
  24. Wibawa  ID, Muljono  DH, Mulyanto , Suryadarma  IG, Tsuda  F, Takahashi  M, Prevalence of antibodies to hepatitis E virus among apparently healthy humans and pigs in Bali, Indonesia: identification of a pig infected with a genotype 4 hepatitis E virus. J Med Virol. 2004;73:3844. DOIPubMed
  25. Takahashi  K, Kang  JH, Ohnishi  S, Hino  K, Mishiro  S. Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis. J Infect Dis. 2002;185:13425. DOIPubMed
  26. Meng  XJ, Wiseman  B, Elvinger  F, Guenette  DK, Toth  TE, Engle  RE, Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002;40:11722. DOIPubMed
  27. Li  SW, Zhang  J, Li  YM, Ou  SH, Huang  GY, He  ZQ, A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine. 2005;23:2893901. DOIPubMed
  28. Purcell  RH, Nguyen  H, Shapiro  M, Engle  RE, Govindarajan  S, Blackwelder  WC, Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine. 2003;21:260715. DOIPubMed
  29. Zhuang  H, Li  K, Zhu  W. Partial nucleotide sequences of hepatitis E viruses isolated from patients in 14 cities of China. [PMID 11236627]. Zhonghua Yi Xue Za Zhi (Taipei). 2000;80:8936.PubMed
  30. Wang  Y, Zhang  H, Li  Z, Gu  W, Lan  H, Hao  W, Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4. J Clin Microbiol. 2001;39:43709. DOIPubMed
  31. Zheng  Y, Ge  SX, Zhang  J, Guo  QS, Ng  MH, Wang  FD, Swine are a principal source of hepatitis E virus infection in eastern China. J Infect Dis. 2006;193:16439. DOIPubMed
  32. Zhang  J, Ge  SX, Huang  GY, Li  SW, He  ZQ, Wang  YB, Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol. 2003;71:51826. DOIPubMed
  33. Ge  SX, Guo  QS, Li  SW, Zhang  J, Xia  NS. Design and primary application of a set of universal RT-PCR primers for genotype 1/4 hepatitis E virus. Bing Du Xue Bao. 2005;21:1817.
  34. Zhang  J, Gu  Y, Ge  SX, Li  SW, He  ZQ, Huang  GY, Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine. 2005;23:288192. DOIPubMed
  35. Agresti  A. Building and applying logistic regression models. In: Agresti A. Categorical data analysis. 2nd ed. New York: John Wiley & Son, Inc.; 2002. p. 211–6.
  36. Zhang  JZ, Im  SW, Lau  SH, Chau  TN, Lai  ST, Ng  SP, Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J Med Virol. 2002;66:408. DOIPubMed
  37. Li  S-W, Zhang  J, He  Z-Q, Gu  Y, Liu  R-S, Lin  J, Mutational analysis of essential interactions involved in the assembly of hHepatitis E virus capsid. J Biol Chem. 2005;280:34006. DOIPubMed
  38. Im  SW, Zhang  JZ, Zhuang  H, Che  XY, Zhu  WF, Xu  GM, A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine. 2001;19:372632. DOIPubMed
  39. Wong  DC, Purcell  RH, Sreenivasan  MA, Prasad  SR, Pavri  KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 1980;2:8769. DOIPubMed




Cite This Article

DOI: 10.3201/eid1211.060332

1Dr. Rong-Cheng Li and Dr. Sheng-Xiang Ge contributed equally to this paper.

2Current affiliation: Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.

Table of Contents – Volume 12, Number 11—November 2006


Please use the form below to submit correspondence to the authors or contact them at the following address:

Ning-Shao Xia, National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Sciences, Xiamen University, Xiamen 361005, People’s Republic of China

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.


Page created: October 14, 2011
Page updated: October 14, 2011
Page reviewed: October 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.